Jonathan L. Kaufman, MD


As the Medical Director of the Winship Cancer Institute Ambulatory Infusion Centers, Dr. Kaufman coordinates the care for over 10,000 cancer patients served each year.

Titles and Roles

Medical Director of the Ambulatory Infusion Centers
Winship Cancer Institute of Emory University
Associate Vice-Chair for Quality Hematology and Medical Oncology
Winship Cancer Institute of Emory University
Associate Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Bone Marrow and Stem Cell Transplant Center
Multiple Myeloma
Phase I Clinical Trials Unit
Research Program
Discovery and Developmental Therapeutics


Jonathan L. Kaufman, MD is board certified in hematology and medical oncology. Dr. Kaufman is an active clinical and translational researcher in the fields of multiple myeloma, amyloidosis, and bone marrow transplant. As a network physician, he started practicing with Emory Healthcare in 2005.

Dr. Kaufman is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He also holds memberships with American Society of Clinical Oncology and American Society of Hematology.


Dr. Kaufman earned his Medical Degree from the Medical College of Georgia in Augusta. He subsequently completed his Residency in Internal Medicine and his Fellowship in Hematology and Oncology at Emory University.


Dr. Kaufman is the recipient of the following awards:

  • ASBMT New Investigator Travel Grant
  • ASCO/AACR Methods in Clinical Cancer Research
  • Best PGY1 Resident
  • Edwin M. Crissey Fellowship
  • The MMRF Accelerator Award
  • Multiple Myeloma Research Foundation


Dr. Kaufman's research focus is on the development of optimal treatment regimens and new drug development for patients with plasma cell disorders.


His work has been published in journals such as Journal of Clinical Oncology, Science Signaling, Blood, Leukemia, Clinical Cancer Research, Journal of Immunology, Cancer, and Clinical Lymphoma and Myeloma. He has served as a reviewer for Clinical Lymphoma and Myeloma, Bone Marrow Transplantation, Clinical Cancer Research and Leukemia. He has presented his clinical research on multiple myeloma at invited institutional lectures, as well as national and international hematology and oncology conferences.

Cascade Link